NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268908. A total of 3 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,137,000 | -40.8% | 650 | +9.8% | 0.47% | +1.7% |
| Q3 2018 | $3,609,000 | +13.0% | 592 | -9.5% | 0.46% | -6.3% |
| Q2 2018 | $3,193,000 | -79.3% | 654 | -54.9% | 0.49% | -46.4% |
| Q1 2018 | $15,408,000 | +363.3% | 1,450 | +160.3% | 0.92% | +203.6% |
| Q4 2017 | $3,326,000 | +2363.7% | 557 | +406.4% | 0.30% | +3687.5% |
| Q4 2016 | $135,000 | -96.3% | 110 | -95.4% | 0.01% | -93.2% |
| Q4 2014 | $3,689,000 | +437.8% | 2,380 | +262.8% | 0.12% | +160.0% |
| Q3 2013 | $686,000 | – | 656 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 9,000 | $5,360 | 0.00% |
| JANE STREET GROUP, LLC | 15,700 | $9,351 | 0.00% |
| SIMPLEX TRADING, LLC | 6,200 | $3 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |